Search Results (13)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| The Interplay between Pharmacokinetics and Pharmacodynamics. | Academic Article |
Why?
|
| Analysis Approaches to Identify Pharmacogenetic Associations With Pharmacodynamics. | Academic Article |
Why?
|
| Assessment of histamine pharmacodynamics by microvasculature response of histamine using histamine iontophoresis laser Doppler flowimetry. | Academic Article |
Why?
|
| Developmental pharmacokinetics and pharmacodynamics of nizatidine. | Academic Article |
Why?
|
| Pharmacokinetics, Pharmacodynamics, and Safety of Lisinopril in Pediatric Kidney Transplant Patients: Implications for Starting Dose Selection. | Academic Article |
Why?
|
| The integration of pharmacokinetics and pharmacodynamics: understanding dose-response. | Academic Article |
Why?
|
| Valproic acid pathway: pharmacokinetics and pharmacodynamics. | Academic Article |
Why?
|
| Effect of Obesity on Pantoprazole Pharmacokinetics and Pharmacodynamics in Children | Grant |
Why?
|
| An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28?days to <?6?years with chronic kidney disease receiving dialysis. | Academic Article |
Why?
|
| Effects of oral vitamin K on S- and R-warfarin pharmacokinetics and pharmacodynamics: enhanced safety of warfarin as a CYP2C9 probe. | Academic Article |
Why?
|
| Phase 1, single-dose study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of etelcalcetide in pediatric patients with secondary hyperparathyroidism receiving hemodialysis. | Academic Article |
Why?
|
| Correction to: An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28?days to <?6?years with chronic kidney disease receiving dialysis. | Academic Article |
Why?
|
| Characterization of the Role of Histamine in Children with Asthma | Grant |
Why?
|